2 completed, 1 enrolling by invitation. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Enrolling by invitation 1 |
| Phase 2 | 1 | Enrolling by invitation 1 |
Follow Hereditary Angioedema Type III: new trials by email Literature Review of Hereditary Angioedema Type III trials Research Report on Hereditary Angioedema Type III
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Oral Deucrictibant Soft Capsule for On-Demand Treatment of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema Deucrictibant, Placebo - Hereditary Angioedema, Hereditary Angioedema Type I | Phase 3 | Completed | Pharvaris Netherlands B.V. | 134 | 2024-02-26 | 2025-11-21 |
| Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema deucrictibant - Hereditary Angioedema, Hereditary Angioedema Type I | Phase 2 / Phase 3 | Enrolling by invitation | Pharvaris Netherlands B.V. | 150 | 2022-12-28 | 2026-07-21 |
| Biomarker for Hereditary AngioEdema Disease C1 Esterase Inhibitor Deficiency, Angio Edema | Completed | CENTOGENE GmbH Rostock | 42 | 2018-08-20 | 2022-03-24 |
Angioedemas, Hereditary (3) · Hereditary Angioedema Types I and II (3) · Angioedema (1)
Cardiovascular Diseases (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Genetic Diseases, Inborn (3) · Hereditary Complement Deficiency Diseases (3) · Hypersensitivity (3) · Hypersensitivity, Immediate (3) · Immune System Diseases (3) · Immunologic Deficiency Syndromes (3) · Primary Immunodeficiency Diseases (3) · Skin Diseases (3) · Skin Diseases, Vascular (3) · Skin and Connective Tissue Diseases (3) · Urticaria (3) · Vascular Diseases (3) · Angioedema (2)
Pharvaris Netherlands B.V. (2) · CENTOGENE GmbH Rostock (1)
Poland (3) · Turkey (Türkiye) (3) · Argentina (2) · Australia (2) · Austria (2) · Brazil (2) · Bulgaria (2) · Canada (2) · Czechia (2) · France (2) · Germany (2) · Hong Kong (2) · Hungary (2) · Italy (2) · Japan (2)
Peter Bauer, MD (1)
2023 (1)